Marina Pasca Di Magliano is a leading researcher in the field of pancreatic cancer, specializing in embryonic signaling pathways and their implications in cancer progression. She is a Professor in the University of Michigan Medical School and holds the Maud T. Lane Professorship in Surgical Immunology. As a faculty member, she leads multiple impactful initiatives, including the Signaling Tumor Microenvironment Program and is Co-Director of the Rogel Cancer Center's Blondy Center for Pancreatic Cancer. Di Magliano's scholarly work has extensively examined the metabolic interactions within the pancreatic tumor microenvironment. She has contributed to significant publications in peer-reviewed journals, showcasing her findings about NADPH-producing enzymes and their roles in pancreatic cancer progression, as well as insights into metabolic dependencies that are essential for cancer cell survival and metastasis. Her research continues to inform therapeutic strategies aimed at improving outcomes for patients with pancreatic cancer, and she is dedicated to mentoring the next generation of scientists in this critical area of study. In recognition of her contributions to science, she was inducted as a Fellow of the American Association for the Advancement of Science in 2022.